These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3048781)

  • 1. Evaluation of an enzyme immunoassay kit for estrogen receptor measurement--report II.
    Raam S; Vrabel DM
    Clin Chem; 1988 Oct; 34(10):2053-7. PubMed ID: 3048781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an enzyme immunoassay kit for estrogen receptor measurements.
    Raam S; Vrabel DM
    Clin Chem; 1986 Aug; 32(8):1496-502. PubMed ID: 2426007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms.
    Cren H; Lechevrel C; Roussel G; Goussard J
    J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):519-27. PubMed ID: 1911441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
    Dittadi R; Meo S; Amoroso B; Gion M
    Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.
    Goussard J; Lechevrel C; Martin PM; Roussel G
    Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whither cytosolic estrogen receptor assays? A comparison of commercially available kits for estrogen receptor assay.
    Bilous AM; Tyler JP; Toppila M; Milliken J
    Pathology; 1987 Jul; 19(3):223-8. PubMed ID: 3324022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
    Thorpe SM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies of estrogen receptor determinations by enzyme immuno-assay using the monoclonal antibody, dextran-coated charcoal, and sucrose density gradient methods].
    Tominaga T; Yoshida Y; Kitamura M; Kosaki G
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1782-6. PubMed ID: 2412495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of dextran coated charcoal (DCC) and enzyme immunoassay (EIA) methods for oestrogen receptor (ER) estimation in breast cancer.
    Redkar AA; Kabre SS; Mittra I
    Indian J Cancer; 1991 Mar; 28(1):9-15. PubMed ID: 1769684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
    Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of nuclear estrogen receptors by an enzyme immunoassay: applicability and caveats.
    Kral LG; Doherty LM; Brooks SC
    J Steroid Biochem; 1988 Oct; 31(4A):459-66. PubMed ID: 3050279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lability of estrogen receptor: correlation of estrogen binding and immunoreactivity.
    Clayton F; Wu J
    Clin Chem; 1986 Sep; 32(9):1774-7. PubMed ID: 3527482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of estrogen receptor isoforms with immobilized monoclonal antibodies.
    Sato N; Hyder SM; Chang L; Thais A; Wittliff JL
    J Chromatogr; 1986 May; 359():475-87. PubMed ID: 3525585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.
    Leclercq G; Bojar H; Goussard J; Nicholson RI; Pichon MF; Piffanelli A; Pousette A; Thorpe S; Lonsdorfer M
    Cancer Res; 1986 Aug; 46(8 Suppl):4233s-4236s. PubMed ID: 2425942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples.
    Marsigliante S; Puddefoot JR; Barker S; Gledhill J; Vinson GP
    J Steroid Biochem Mol Biol; 1990 Dec; 37(5):643-8. PubMed ID: 2278849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
    Kiang DT; Kollander R
    J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of estrogen receptors in human breast cancer: comparison between enzyme immunoassay and dextran-coated charcoal method.
    Bozzetti C; Naldi N; Guazzi A; Nizzoli R; Benecchi M; Cocconi G
    Tumori; 1986 Oct; 72(5):511-4. PubMed ID: 2432712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the 8S complex in oestrogen receptor recognition.
    Marsigliante S; Puddefoot JR; Barker S; Goode AW; Vinson GP
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):703-11. PubMed ID: 1958507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United States.
    Jordan VC; Jacobson HI; Keenan EJ
    Cancer Res; 1986 Aug; 46(8 Suppl):4237s-4240s. PubMed ID: 3524804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.